The decision desk
AI literature screening: Rayyan vs DistillerSR vs ASReview
Compare three AI-assisted products for screening imported literature against a review question. The focus is systematic inclusion decisions and evidence workflows, rather than general web research or chat answers.
Our take
Rayyan combines collaborative screening with tiered AI, DistillerSR joins screening and evidence management, and ASReview LAB concentrates on transparent active-learning prioritization.
The quick difference
3 tools, at a glance
Start with the fit. Read the individual breakdowns below before choosing. Scroll the table on smaller screens.
| Tool | Best fit | Main strengths | What to check |
|---|---|---|---|
| Rayyan | Research teams combining screening decisions with deduplication and structured review management. | AI relevance predictions · Collaborative title, abstract, and full-text screening · PICO extraction in Advanced and ResearchPilot in institutional tiers | ResearchPilot is not included in every paid tier. |
| DistillerSR | Evidence teams needing auditable review workflows and organization-wide evidence reuse. | AI Rerank learns from screening decisions · Smart Screening for title and abstract decisions · Smart Evidence Extraction with configurable human oversight | Smart Screening and Smart Evidence Extraction are distinct capabilities. |
| ASReview LAB | Researchers wanting transparent, self-managed AI-assisted screening and model simulation. | Active-learning prioritization from reviewer labels · Configurable models and simulation on labeled data · Import, label management, and result export | Hosting and software operation remain the research team’s responsibility. |
Compare pricing, features, and source dates
Prices describe the named plan, not total cost. Different billing units are not directly equivalent. Scroll the table horizontally on smaller screens.
| At a glance | RayyanVendor documentation | DistillerSRVendor documentation | ASReview LABVendor documentation |
|---|---|---|---|
| Consider it for | Research teams combining screening decisions with deduplication and structured review management. | Evidence teams needing auditable review workflows and organization-wide evidence reuse. | Researchers wanting transparent, self-managed AI-assisted screening and model simulation. |
| Named plan / entry point | Advanced $8.33/seat/mo billed annually seat/month equivalent; annual billing | Custom quote; amount unconfirmed contract; billing interval unconfirmed | Free open-source software; self-managed software license; infrastructure costs separate |
| Free option | Available | Unconfirmed | Available |
| Documented features |
|
|
|
| Limitations |
|
|
|
| Integrations | Check the official product documentation | Check the official product documentation | Check the official product documentation |
| Billing details | Free includes 3 active reviews, 2 free reviewers, 1 sample and AI relevance predictions. Advanced is $8.33/seat/month billed annually, or $13.33/month billed quarterly; it adds 9 active reviews, 10 free reviewers and PICO extraction. Essential is $4.99/seat/month annually or $8.33/month quarterly. Institutional Business/Academic lists $41.67/license/month annually with a five-license $2,500 starting total; ResearchPilot belongs to institutional scope. Academic discounts and checkout totals should be confirmed. | No current numeric amount, contract interval or permanent free plan was publicly established. Request a scoped proposal covering the platform, AI Rerank, Smart Screening, Smart Evidence Extraction, reference volumes and users. The September 10, 2026 launch describes up to 100,000 abstracts per Smart Screening run; that processing capacity is not a subscription entitlement or accuracy guarantee. | Open-source software under Apache 2.0 with no recurring software license fee for self-managed use. Computing, hosting, support and team administration can still create costs. This is not a hosted enterprise service quote or a promise of unlimited managed support. |
| Last checked | Oct 8, 2026 Official source | Oct 8, 2026 Official source | Oct 8, 2026 Official source |
Turn a reference set into a review workflow
Systematic-review screening starts with a set of references and a defined inclusion question. Rayyan, DistillerSR, and ASReview LAB help reviewers find relevant studies, but the word AI covers different functions in each product. Reordering a queue, proposing an inclusion decision, and extracting study data are separate capabilities. The comparison below follows those differences and the workflow around the reviewer’s decisions.
Rayyan
Rayyan provides a shared environment for importing references, detecting duplicates, screening titles and abstracts, and continuing into full-text decisions and structured data. Its AI relevance predictions help reviewers prioritize attention while collaboration features keep inclusion choices, labels, and conflicts in the review workflow. Sampling offers a way to divide subsets among team members, and the mobile app supports screening away from the desktop. That breadth makes Rayyan useful for researchers who want a recognizable systematic-review workspace rather than a separate modeling tool. The plan boundary is especially important. Basic relevance predictions appear in the Free plan, while Advanced adds AI PICO extraction and larger review and reviewer allowances. ResearchPilot, with more extensive AI screening and extraction capabilities, is associated with institutional tiers. Rayyan suits academic and research teams that want collaboration, screening, and reporting in one service, with a package they can expand. Its basic predictions should not be described as equivalent to the institutional ResearchPilot feature set.
DistillerSR
DistillerSR combines configurable literature-review workflows with AI screening, evidence extraction, and reuse across an organization. Its AI Rerank learns from reviewers’ inclusion and exclusion decisions and reprioritizes references as work continues. AI error checking can flag potentially mistaken exclusions, while classifiers can help label and route references. The newer Smart Screening capability, launched in September 2026, evaluates titles and abstracts in a human-in-the-loop or automated workflow, with decision rationales and tracked activity. That is distinct from simply sorting a queue. Smart Evidence Extraction then supports finding and suggesting answers from source documents for extraction forms. DistillerSR suits evidence-generation teams that need screening to connect with configurable forms, reporting, and reusable evidence rather than stop at an exported shortlist. Its value depends on selecting the appropriate capabilities and human oversight for the work. The vendor’s processing capacity and pilot statistics do not establish the quality of a team’s own review or the allowances in its subscription.
ASReview LAB
ASReview LAB focuses on active learning for screening textual datasets. Reviewers import a reference set, provide relevant or irrelevant labels, and let the model prioritize which record to inspect next. The reviewer remains the source of inclusion decisions; the model learns from those decisions to make the queue more useful. The current open-source project offers configurable model components, automatic saving of labels, and exports of labeled data or project files. A simulation toolkit can assess model behavior on fully labeled datasets, giving researchers a way to study the screening method itself. Current version-three documentation also describes hiding duplicate records during screening and editable tags. ASReview LAB suits researchers who value transparent models, reproducible projects, and control over where the software runs. Its free software license comes with the responsibility for installing or hosting the application. It is a more focused screening companion than a managed evidence platform with procurement, extraction, and organization-wide administration bundled together.
Prioritization versus screening decisions
ASReview LAB centers on choosing the next useful record for a human reviewer. Rayyan includes relevance predictions in its basic workflow and reserves more extensive ResearchPilot functions for institutional scope. DistillerSR offers both adaptive reranking and a separate Smart Screening decision capability. These distinctions matter when comparing claims about AI screening. A team wanting to keep every inclusion decision with a reviewer can use prioritization; a team seeking proposed or automated decisions needs the relevant capability and the corresponding review workflow. Those are different purchases and different operating choices.
What happens after the shortlist
Rayyan continues through full-text screening, data extraction, and reporting within its review environment, with access varying by tier. DistillerSR places configurable extraction and evidence reuse alongside screening, making it relevant to organizations maintaining several reviews or recurring evidence programs. ASReview LAB saves labels and exports the dataset or project, but its central purpose remains screening prioritization. Rayyan is a natural fit for a collaborative review team, DistillerSR for a wider evidence-management process, and ASReview for a research group that wants the screening model to remain a distinct, controlled component.
Free software, free plans, and institutional AI
ASReview LAB has no recurring software license fee, although hosting and operation still take resources. Rayyan’s Free plan includes three active reviews and relevance predictions; Advanced is $8.33 per seat per month billed annually, while ResearchPilot belongs to institutional scope with separate minimums. DistillerSR’s current amount and contract interval require a proposal defining the AI modules. The useful cost comparison is therefore a self-managed screening tool, a hosted review package, or an evidence platform with specific automation capabilities. A free entry point does not imply that every AI function is included.
Which should you choose?
Consider Rayyan for collaborative reviews with a tiered path into AI features, DistillerSR for configurable screening connected with enterprise evidence management, and ASReview LAB for transparent active-learning prioritization you can operate yourself. Match the choice to the reviewer’s role and the work after screening.
Sources & methodology
This article uses vendor documentation and our editorial analysis. We have not performed a controlled hands-on test. Product facts were checked on Oct 8, 2026; each profile records its own verification date.
- Rayyan profile and source notes · Current systematic-review product · Plans and AI scope
- DistillerSR profile and source notes · Current platform and evidence reuse · AI tools and extraction · Smart Screening launch and scope
- ASReview LAB profile and source notes · Current ASReview project · Installation and deployment · Official repository, features, and license